CLINICAL_TRIALS
trial_result
· 2024-10-18
Clinical Trial Update: Safety Study of Gene Therapy in Treating Critical Leg Ischemia [Phase 1]
Summary
Phase 1 safety study of a gene therapy for critical limb ischemia has been completed. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Helixmith Co., Ltd. | Conditions: Critical Limb Ischemia | Phase 1 | Status: COMPLETED | Results posted: 2024-10-18